DexCom (DXCM)
(Delayed Data from NSDQ)
$112.13 USD
+0.48 (0.43%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $112.47 +0.34 (0.30%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DXCM 112.13 +0.48(0.43%)
Will DXCM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for DXCM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DXCM
CGM Sensor Demand Likely to Drive DexCom (DXCM) Q2 Earnings
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates
DXCM: What are Zacks experts saying now?
Zacks Private Portfolio Services
AMN Healthcare (AMN) Unveils ShiftWise Flex Manager Hub App
BD (BDX) Up on Efforts to Tackle Blood Culture Vial Shortage
How to Play Intuitive Surgical (ISRG) Ahead of Q2 Earnings?
Other News for DXCM
Dexcom’s Market Leadership and Strategic Growth Opportunities Affirm Buy Rating
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
Tandem Diabetes, DexCom see weakness following ADA conference